Linc AB
Europe, Stockholms Lan, Sweden, Stockholm
Description
Linc AB invests in product oriented companies in the Nordic Life Science industry.
Investor Profile
Linc AB has made 8 investments, with 2 in the past 12 months and 13% as lead.
Stage Focus
- Series Unknown (25%)
- Secondary Market (13%)
- Post Ipo Equity (13%)
- Series C (13%)
- Seed (13%)
- Post Ipo Debt (13%)
- Series B (13%)
Country Focus
- Sweden (75%)
- Denmark (25%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Biopharma
- Clinical Trials
- Therapeutics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
